Skip to main content
Log in

Neuroimaging the Effectiveness of Substance Use Disorder Treatments

  • BRIEF REPORT
  • Published:
Journal of Neuroimmune Pharmacology Aims and scope Submit manuscript

Abstract

Neuroimaging techniques to measure the function and biochemistry of the human brain such as positron emission tomography (PET), proton magnetic resonance spectroscopy (1H MRS), and functional magnetic resonance imaging (fMRI), are powerful tools for assessing neurobiological mechanisms underlying the response to treatments in substance use disorders. Here, we review the neuroimaging literature on pharmacological and behavioral treatment in substance use disorder. We focus on neural effects of medications that reduce craving (e.g., naltrexone, bupropion hydrochloride, baclofen, methadone, varenicline) and that improve cognitive control (e.g., modafinil, N-acetylcysteine), of behavioral treatments for substance use disorders (e.g., cognitive bias modification training, virtual reality, motivational interventions) and neuromodulatory interventions such as neurofeedback and transcranial magnetic stimulation. A consistent finding for the effectiveness of therapeutic interventions identifies the improvement of executive control networks and the dampening of limbic activation, highlighting their values as targets for therapeutic interventions in substance use disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig 1
Fig 2

Similar content being viewed by others

References

Download references

Acknowledgments

The authors thank Dr. Joanna Fowler for proofreading.

This work was supported by NIH/NIAAA intramural grant Y1AA-3009 to NDV.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elizabeth A. Cabrera.

Ethics declarations

Conflicts of Interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cabrera, E.A., Wiers, C.E., Lindgren, E. et al. Neuroimaging the Effectiveness of Substance Use Disorder Treatments. J Neuroimmune Pharmacol 11, 408–433 (2016). https://doi.org/10.1007/s11481-016-9680-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11481-016-9680-y

Keywords

Navigation